SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Before you automate a process with AI, ask whether it should still exist

Former Apax Israel No. 2 seeks to raise $165 million fund amid legal battle with Zehavit Cohen

Amazon crosses $3 trillion valuation for the first time as AI boom lifts cloud business

Palantir's AI battlefield software fuels another surge in revenue expectations

Buzz

Most popular

Daily

Weekly

1

Salesforce veterans raise $20 million pre-Seed from Marc Benioff and Michael Dell to tackle AI’s enterprise bottleneck

2

Billionaire Beny Steinmetz challenges $1.4 million tax demand over $9 million Israeli home sale

3

Deel acquires Israeli deepfake security startup Clarity in $40-50 million deal

4

Visa acquires Israeli fraud prevention company BioCatch for $2.4 billion

5

Israel searches for technology that could find soldiers and pilots who cannot call for help

Colossal Biosciences

1 stories about Colossal Biosciences

Sam Lamm holding Romulus, one of the cubs

"We took a 73,000-year-old fossil and created puppies from it. It's just magic"

02.06.25|Roni Dori

Biotech venture Colossal Biosciences stunned the world in April with the announcement that it had genetically engineered the dire wolf, a species that went extinct 12,500 years ago. But the excitement over the birth of three white puppies was quickly tempered by criticism: skeptics argued this was not a true species revival and warned that such investments could divert attention and resources from the urgent effort to protect existing wildlife. In an exclusive interview, founder Ben Lamm explains how the complex process was achieved, and why he believes it could ultimately benefit the planet.